Market Tracker

04/26 5:16pm ET

Novelion Therapeutics Inc (NASDAQ:NVLN)

10.04
Delayed Data
As of 3:59pm ET
 -0.05 / -0.50%
Today’s Change
6.10
Today|||52-Week Range
13.80
+19.24%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close10.09
Today’s open10.02
Day’s range9.94 - 10.20
Volume94,088
Average volume (3 months)105,320
Market cap$187.3M
Dividend yield39.02%
Data as of 3:59pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)-450.00%
Earnings growth (this year)-1.14%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
NATRNatures Sunshine Pro...+0.25+2.53%
CTSOCytosorbents Corp+0.15+3.00%
CDTXCidara Therapeutics ...+0.25+3.36%
CDXCChromadex Corp+0.14+5.93%
Data as of 3:59pm ET, 04/26/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$0.00
Annual profit (last year)-$23.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Director, Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Vancouver, British Columbia

Forecasts